Who invested in Ignis Therapeutics?
Ignis Therapeutics's investors include Goldman Sachs, KB Investment and Mubadala.
Who invested in Ignis Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Get an email when Ignis Therapeutics raises a new round.Sign up free
Funding summaryUpdated 27 Oct 2026
$2.8Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $2.8MJan 2023
- Investors
- 3
The rounds
- Jan 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ignis Therapeutics
How much has Ignis Therapeutics raised?
Ignis Therapeutics has raised $2.8M across 1 round since 2023.
When did Ignis Therapeutics last raise?
Ignis Therapeutics's most recent round was a Series A of $2.8M in Jan 2023.
What was Ignis Therapeutics's biggest round?
Its most recent round, $2.8M in Jan 2023, is also its largest on record.
Who backed Ignis Therapeutics first?
Ignis Therapeutics's first round on record, in Jan 2023, was backed by Goldman Sachs, KB Investment and Mubadala.
What stage is Ignis Therapeutics at?
Ignis Therapeutics's latest named round is a Series A, in Jan 2023.
Companies like Ignis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.